{"id":"https://openalex.org/W4410869737","doi":"https://doi.org/10.3390/pharmaceutics17060702","title":"Application of Solvent Evaporation to Generate Supersaturated Lipid-Based Formulations: Investigation of Drug Load and Formulation Quality","display_name":"Application of Solvent Evaporation to Generate Supersaturated Lipid-Based Formulations: Investigation of Drug Load and Formulation Quality","alternate_titles":[],"publication_year":2025,"publication_date":"2025-05-27","ids":{"openalex":"https://openalex.org/W4410869737","doi":"https://doi.org/10.3390/pharmaceutics17060702","pmid":"https://pubmed.ncbi.nlm.nih.gov/40574015","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12196494"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics17060702","doi":"https://doi.org/10.3390/pharmaceutics17060702","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics17060702","pdf_url":"https://www.mdpi.com/1999-4923/17/6/702/pdf?version=1748346260","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4410869737"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/17/6/702/pdf?version=1748346260","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103049603","display_name":"Felix Paulus","orcid":"https://orcid.org/0000-0003-1323-6891","observed_orcids":["https://orcid.org/0000-0003-1323-6891"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]},{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["BE","DK"],"is_corresponding":false,"raw_author_name":"Felix Paulus","raw_affiliation_strings":["Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark","Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark","institution_ids":["https://openalex.org/I177969490"]},{"raw_affiliation_string":"Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069835240","display_name":"Jef Stappaerts","orcid":"https://orcid.org/0000-0002-4870-9743","observed_orcids":["https://orcid.org/0000-0002-4870-9743"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jef Stappaerts","raw_affiliation_strings":["Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053662272","display_name":"Annette Bauer\u2010Brandl","orcid":"https://orcid.org/0000-0002-8238-6984","observed_orcids":["https://orcid.org/0000-0002-8238-6984"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Annette Bauer-Brandl","raw_affiliation_strings":["Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark"],"raw_orcid":"https://orcid.org/0000-0002-8238-6984","affiliations":[{"raw_affiliation_string":"Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark","institution_ids":["https://openalex.org/I177969490"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dirk Lauwers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Dirk Lauwers","raw_affiliation_strings":["Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Liesbet Smet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Liesbet Smet","raw_affiliation_strings":["Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078226138","display_name":"Eline Hermans","orcid":"https://orcid.org/0000-0002-4725-3107","observed_orcids":["https://orcid.org/0000-0002-4725-3107"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eline Hermans","raw_affiliation_strings":["Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066208508","display_name":"Ren\u00e9 Holm","orcid":"https://orcid.org/0000-0003-4894-7765","observed_orcids":["https://orcid.org/0000-0003-4894-7765"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Ren\u00e9 Holm","raw_affiliation_strings":["Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark"],"raw_orcid":"https://orcid.org/0000-0003-4894-7765","affiliations":[{"raw_affiliation_string":"Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230 Odense, Denmark","institution_ids":["https://openalex.org/I177969490"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5066208508"],"corresponding_institution_ids":["https://openalex.org/I177969490"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.3184,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.44362601,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"17","issue":"6","first_page":"702","last_page":"702"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipid-based-formulations","display_name":"lipid-based formulations","score":0.9129999876022339},{"id":"https://openalex.org/keywords/supersaturation","display_name":"supersaturation","score":0.8709999918937683},{"id":"https://openalex.org/keywords/solvent-evaporation","display_name":"solvent evaporation","score":0.9900000095367432},{"id":"https://openalex.org/keywords/drug-loading","display_name":"drug loading","score":0.6880000233650208},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.699999988079071},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":1.0},{"id":"https://openalex.org/keywords/bcs-class-ii-drugs","display_name":"BCS class II drugs","score":0.8180000185966492},{"id":"https://openalex.org/keywords/dichloromethane","display_name":"dichloromethane","score":0.8059999942779541},{"id":"https://openalex.org/keywords/residual-solvents","display_name":"residual solvents","score":0.7250000238418579},{"id":"https://openalex.org/keywords/physical-stability","display_name":"physical stability","score":0.9259999990463257},{"id":"https://openalex.org/keywords/precipitation-chemistry","display_name":"precipitation chemistry","score":0.7279999852180481},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.906000018119812}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.8352484703063965},{"id":"https://openalex.org/C200447597","wikidata":"https://www.wikidata.org/wiki/Q334104","display_name":"Supersaturation","level":2,"score":0.810808002948761},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7107243537902832},{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.7066215872764587},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.6226296424865723},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5345678925514221},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.27974817156791687},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.13983556628227234},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/pharmaceutics17060702","doi":"https://doi.org/10.3390/pharmaceutics17060702","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics17060702","pdf_url":"https://www.mdpi.com/1999-4923/17/6/702/pdf?version=1748346260","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmh:oai:sdu.dk:openaire/f5c67609-a81c-42d2-9c85-36456b75e813","doi":null,"is_oa":true,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/f5c67609-a81c-42d2-9c85-36456b75e813","pdf_url":"https://portal.findresearcher.sdu.dk/files/292366255/pharmaceutics-17-00702_1_.pdf","source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Paulus, F, Stappaerts, J, Bauer-Brandl, A, Lauwers, D, Smet, L, Hermans, E & Holm, R 2025, 'Application of Solvent Evaporation to Generate Supersaturated Lipid-Based Formulations : Investigation of Drug Load and Formulation Quality', Pharmaceutics, vol. 17, no. 6, 702. https://doi.org/10.3390/pharmaceutics17060702","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:40574015","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40574015","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12196494","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12196494/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:771c7a5dea0f47e398e851a5584765e8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/771c7a5dea0f47e398e851a5584765e8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 17, Iss 6, p 702 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics17060702","doi":"https://doi.org/10.3390/pharmaceutics17060702","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics17060702","pdf_url":"https://www.mdpi.com/1999-4923/17/6/702/pdf?version=1748346260","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.7246000170707703,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G434337789","display_name":null,"funder_award_id":"HORIZON2020","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G5241279497","display_name":"A fully integrated, animal-free, end-to-end modelling approach to oral drug product development","funder_award_id":"955756","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4410869737.pdf","grobid_xml":"https://content.openalex.org/works/W4410869737.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1983870125","https://openalex.org/W1995321650","https://openalex.org/W2041016731","https://openalex.org/W2053770992","https://openalex.org/W2056995570","https://openalex.org/W2087545318","https://openalex.org/W2089926889","https://openalex.org/W2164246656","https://openalex.org/W2165548590","https://openalex.org/W2177886515","https://openalex.org/W2571429454","https://openalex.org/W2771797119","https://openalex.org/W2779048322","https://openalex.org/W2905424224","https://openalex.org/W2954528354","https://openalex.org/W3002657783","https://openalex.org/W3006419991","https://openalex.org/W3015686307","https://openalex.org/W3027697088","https://openalex.org/W3030925034","https://openalex.org/W3036266787","https://openalex.org/W3040312161","https://openalex.org/W3043613626","https://openalex.org/W3044010896","https://openalex.org/W3114606751","https://openalex.org/W3116035503","https://openalex.org/W3169596185","https://openalex.org/W3198310983","https://openalex.org/W4319972409","https://openalex.org/W4384695333","https://openalex.org/W4385597742","https://openalex.org/W4388343328","https://openalex.org/W4388584797","https://openalex.org/W4393045889"],"related_works":["https://openalex.org/W4401728796","https://openalex.org/W4385597742","https://openalex.org/W7140136974","https://openalex.org/W2044779642","https://openalex.org/W3204955767","https://openalex.org/W1994505523","https://openalex.org/W4405316074","https://openalex.org/W6958537801","https://openalex.org/W2779048322","https://openalex.org/W2001033857"],"abstract_inverted_index":{"Background/Objectives:":[0],"Lipid-based":[1],"formulations":[2,6,276],"(LBFs)":[3],"are":[4,57],"enabling":[5],"for":[7,67,206,210,232,236,332],"poorly":[8],"water-soluble,":[9],"mostly":[10],"lipophilic":[11],"drugs.":[12],"In":[13,30,104,273],"LBFs,":[14],"the":[15,20,33,44,48,52,65,75,79,94,126,132,139,152,158,167,172,189,217,223,242,248,266,283,297,310,314,321,328],"drug":[16,40,45,76,123,129,202,226],"is":[17,41,72,149,164,174],"pre-dissolved":[18],"in":[19,47,64,70,78,113,117,131,156,180,241,309],"formulation":[21,95],"which":[22,157,171],"can":[23],"consist":[24],"of":[25,35,38,128,204,228],"lipids,":[26],"surfactants,":[27],"and/or":[28],"cosolvents.":[29],"cases":[31],"where":[32],"administration":[34,53,101],"high":[36,162,316],"amounts":[37],"a":[39,161,290],"required,":[42],"exceeding":[43],"solubility":[46,163,218],"lipidic":[49,80],"vehicle":[50,81],"at":[51,82,87,219,270],"temperature,":[54,85],"supersaturated":[55,254,334],"LBFs":[56,71,114,186,243,267],"an":[58,83,107],"option.":[59],"The":[60],"standard":[61],"method":[62],"described":[63],"literature":[66],"inducing":[68,198],"supersaturation":[69,112,199],"to":[73,97,110,119,138,166,216,230,263,281,305],"dissolve":[74],"substance":[77],"elevated":[84],"e.g.,":[86],"60":[88],"\u00b0C,":[89],"and":[90,155,194,208,234,260,320],"then":[91],"subsequently":[92],"let":[93],"cool":[96],"ambient":[98,220,271],"temperature":[99],"before":[100],"(heat-based":[102],"approach).":[103],"this":[105,181],"work,":[106],"alternative":[108],"approach":[109,329],"induce":[111],"was":[115],"investigated":[116],"order":[118],"evaluate":[120],"if":[121],"higher":[122],"loads,":[124],"i.e.,":[125],"concentration":[127,319],"dissolved":[130],"vehicle,":[133],"could":[134,212,238],"be":[135,213,239],"reached":[136],"compared":[137,179],"loading":[140],"obtainable":[141],"via":[142],"heating.":[143],"Methods:":[144],"A":[145],"volatile":[146,249],"solvent":[147,173,287],"that":[148,296],"miscible":[150],"with":[151,188,279,303],"lipid":[153,168],"matrix":[154],"compound":[159],"has":[160],"added":[165],"matrix,":[169],"after":[170,286],"evaporated.":[175],"Both":[176],"approaches":[177],"were":[178,268,277],"work":[182],"investigating":[183],"two":[184],"different":[185],"loaded":[187],"BCS-class":[190],"II":[191],"drugs":[192],"celecoxib":[193,207,233],"fenofibrate.":[195],"Results:":[196],"When":[197],"by":[200],"heat,":[201],"loads":[203,227],"238%":[205],"278%":[209],"fenofibrate":[211,237],"achieved":[214],"relative":[215],"temperature.":[221,272],"Using":[222],"solvent-based":[224],"approach,":[225],"up":[229,304],"475%":[231],"557%":[235],"prepared":[240],"using":[244,289],"dichloromethane":[245],"(DCM)":[246],"as":[247],"solvent.":[250],"However,":[251],"those":[252],"highly":[253],"preparations":[255],"showed":[256],"suboptimal":[257,322],"physical":[258,323],"stability":[259,324],"quickly":[261],"led":[262],"precipitation":[264],"when":[265],"stored":[269],"addition,":[274],"selected":[275],"analyzed":[278],"GC-headspace":[280],"determine":[282],"residual":[284,317],"DCM":[285,298,308,318],"evaporation":[288],"vacuum":[291],"evaporator.":[292],"This":[293],"analysis":[294],"revealed":[295],"content":[299],"exceeded":[300],"regulatory":[301],"requirements,":[302],"21,883":[306],"ppm":[307],"formulations.":[311,336],"Conclusions:":[312],"Overall,":[313],"relatively":[315],"do":[325],"not":[326],"make":[327],"easily":[330],"usable":[331],"generating":[333],"lipid-based":[335]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4410869737","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2025-10-10T00:00:00"}
